CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 9, 2024 · earnings

ACAD earnings: a negative outcome, -11.2%

On May 9, 2024, ACADIA Pharmaceuticals Inc. reached its earnings. The result was a negative outcome, and the stock moved -11.2% in the window around the event. It had already run -6.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$17.13
1d before
$15.21
Event day
$15.25
1d after
$14.86
5d after

Pre-catalyst setup

-6.3%
30-day run-up
2360%
30-day volatility
1.4×
volume spike